Skip to main content
Atrás
Watch Compare

Opus Genetics, Inc.

Calidad de datos: 100%
IRD
Nasdaq Manufacturing Chemicals
$5.46
▲ $0.31 (6.02%)
Cap. Mercado: 389.69 M
Precio
$5.46
Cap. Mercado
389.69 M
Rango del Día
$5.07 — $5.57
Rango de 52 Semanas
$0.65 — $5.57
Volumen
789,058
Apertura $5.11
Promedio 50D / 200D
$3.90
40.11% above
Promedio 50D / 200D
$2.21
147.09% above

Quick Summary

Puntos Clave

Revenue grew 121.57% annually over 5 years — strong growth
Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -35.25 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 92.42%

Crecimiento

Revenue Growth (5Y)
121.57%
Above sector avg (1.82%)
Revenue (1Y)29.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-423.13%
Below sector avg (-53.41%)
ROIC-239.09%
Net Margin-349.33%
Op. Margin-271.90%

Seguridad

Debt / Equity
0.18
Below sector avg (0.31)
Current Ratio1.23
Interest Coverage-299.22

Valoración

PE (TTM)
-7.86
Below sector avg (-1.48)
P/B Ratio65.31
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -7.9 -1.5
P/B 65.3 1.6
ROE % -423.1 -53.4
Net Margin % -349.3 -41.5
Rev Growth 5Y % 121.6 1.8
D/E 0.2 0.3

ETFs Holding This Stock

BOSVX BOSVX
0.00% weight
BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 29.15% Revenue Growth (3Y) -13.67%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 121.57% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14.20 M Net Income (TTM) -49.59 M
ROE -423.13% ROA -132.62%
Gross Margin N/A Operating Margin -271.90%
Net Margin -349.33% Free Cash Flow (TTM) -35.25 M
ROIC -239.09% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.18 Current Ratio 1.23
Interest Coverage -299.22 Asset Turnover 0.38
Working Capital 6.82 M Tangible Book Value 5.97 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.86 Forward P/E N/A
P/B Ratio 65.31 P/S Ratio 27.45
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9.05%
Market Cap 389.69 M Enterprise Value 359.94 M
Per Share
EPS (Diluted TTM) -0.80 Revenue / Share 0.20
FCF / Share -0.49 OCF / Share -0.49
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 71.09%
SBC-Adj. FCF -38.65 M Growth Momentum -92.42

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 14.20 M 10.99 M 19.05 M 39.85 M 589,000.0
Net Income -49.59 M -57.53 M -9.99 M 17.89 M -56.69 M
EPS (Diluted) -0.80 -2.15 -0.46 0.87 -3.82
Gross Profit — — — — —
Operating Income -38.60 M -62.07 M -10.56 M 18.23 M -22.71 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 129,000.0 — 0.0 9,000.0 2,000.0
Income Tax 0.0 0.0 12,000.0 315,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50.24 M 36.86 M 53.95 M 48.99 M 26.08 M
Total Liabilities 34.90 M 11.30 M 4.04 M 2.75 M 3.86 M
Shareholders' Equity 15.35 M 6.72 M 49.91 M 46.24 M 22.22 M
Total Debt 1.13 M — 600,000.0 0.0 538,000.0
Cash & Equivalents 45.09 M 30.32 M 50.50 M 42.63 M —
Current Assets 50.04 M 36.61 M 53.95 M 48.99 M 26.07 M
Current Liabilities 7.78 M 11.30 M 4.04 M 2.75 M 3.86 M